First Trust Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,496,007
Closed -$32.1M – 171
2026
Q1
$32.1M Buy
+1,496,007
New +$21.1M 1.69% 14

Other funds holding DAWN

First Trust Capital Management's DAWN Position: Q2 2026 in Review

First Trust Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 1,496,007 shares — an estimated $32.1M sold.

First Trust Capital Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $32.1M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • First Trust Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • First Trust Capital Management sold 1,496,007 Day One Biopharmaceuticals shares in Q2 2026, an estimated $32.1M.
  • First Trust Capital Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
  • First Trust Capital Management's Day One Biopharmaceuticals position peaked at $32.1M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on First Trust Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.